Navigation Links
Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
Date:10/26/2007

Analysis of study showed effect size of VYVANSE ranged from 1.39 to 1.73

BOSTON, Oct. 26 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, today announced results from an analysis of VYVANSE(TM) (lisdexamfetamine dimesylate) effect size. These findings were presented today at a national meeting of psychiatrists in Boston. Effect size is a standardized and scientific method of comparing effectiveness of medications evaluated in different studies for the same condition. In general, effect sizes are categorized as small (0.2), medium (0.5) and large (0.8).

An analysis of the phase III pivotal study in pediatric patients with Attention Deficit Hyperactivity Disorder (ADHD) showed the effect size of VYVANSE was 1.39, 1.42 and 1.73 for 30 mg, 50 mg and 70 mg, respectively. This analysis was conducted to establish that the effect size of VYVANSE was due to the medication's effectiveness and not due to two potential influencing factors: the precision of measurement as indexed by standard deviation of endpoint scores, and the size of baseline versus endpoint placebo effect. The findings show that neither of these factors played a role in determining the effect size of VYVANSE. The relationship between effect size and clinical benefit has not been established.

"I'm encouraged that in our analysis, VYVANSE showed a large effect size," said Stephen Faraone, Ph.D., director of medical genetics research and head of child and adolescent psychiatry research at SUNY Upstate Medical University, who led the analysis. "This further supports our belief that VYVANSE is an effective treatment option for children with ADHD."

VYVANSE is a prodrug of d-amphetamine and is approved in the U.S. for the treatment of ADHD in children aged 6 to 12 years.

About ADHD

Approximately 7.8 percent of all school-age children, or about 4.4 million U.S. children aged 4 to 17 years, have been diag
'/>"/>

SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
2. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
6. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
7. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...OD, Ill., Nov. 20 /PRNewswire-FirstCall/ -- Lan...lts for the fiscal fourth quarter and full year of..., The company will host a conference call for inv...Eastern Time. Investors may access the live call b...nd Canada), or 480-629-9835 (international callers...
(Date:11/20/2009)...ISBURG, Pa., Nov. 20 Th...H1N1 flu shots to members of priority groups that ... A total of 18 clinics are being held statewide on... to 8 p.m. Hours on Saturday, Nov. 21, will be 8 a... operate from 2 p.m. to 8 p.m. ,, Individuals ...
(Date:11/20/2009)...EW YORK, Nov. 20 Reportlinker.com ...ilable in its catalogue. ,, Global Self Monito...ion to Drive Growth ,, http://www.reportlink...se-Market-(SMBG )-Increasing-Adoption-to-Drive-Gro...mp;utm_campaign=prnewswire ,, Description ,...
Breaking Medicine Technology:Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Varian Medical Systems to Exhibit a Wide Selection of Flat Panel X Ray Image Detectors and X Ray Tubes at the CMEF Show in Chengdu China 5780 1Varian Medical Systems to Exhibit a Wide Selection of Flat Panel X Ray Image Detectors and X Ray Tubes at the CMEF Show in Chengdu China 5780 2Rules Based Medicine Introduces CardiovascularMAP 28TM 29 Multiplex Biomarker Panel to Aid CVD Drug Development 5775 1Rules Based Medicine Introduces CardiovascularMAP 28TM 29 Multiplex Biomarker Panel to Aid CVD Drug Development 5775 2Rules Based Medicine Introduces CardiovascularMAP 28TM 29 Multiplex Biomarker Panel to Aid CVD Drug Development 5775 3DigitalPersona to Speak at Dallas SecureWorld Expo 10550 1DigitalPersona to Speak at Dallas SecureWorld Expo 10550 2
...ata Support NDA Submission -, TAMPA, Fla., Oct. 2...halmic-focused biopharmaceutical company,announced...ifluprednate,(ST-601) program, which evaluated the...on in the eye following ocular surgery. "We are v...ednate,s,potential as a potent, well-tolerated ste...
...0 preclinical data presented by Dr. Peter Jones, D...ancer Center, SAN FRANCISCO, Oct. 25 SuperGen In...ted to the discovery, rapid,development and commer...tological malignancies, today announced as part of...RTC International Conference that,S110, the Compan...
Other Medicine Technology:Sirion Therapeutics Announces Positive Phase III Results for Difluprednate 2Sirion Therapeutics Announces Positive Phase III Results for Difluprednate 3Sirion Therapeutics Announces Positive Phase III Results for Difluprednate 4SuperGen's Novel Hypomethylating Agent Highlighted at AACR Plenary Session 2SuperGen's Novel Hypomethylating Agent Highlighted at AACR Plenary Session 3
(Date:11/21/2009)..., , WASHINGTON, Nov. 21 /PRNewswire-USNewsw...g statement after the Senate voted to begin full d..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...other historic step on the road to enacting health...al hurdle, senators will now have an opportunity t...
(Date:11/21/2009)..., , Association Discusses Key Provisions o...th Care Reform ,, ST. CHARLES, Ill., Nov. 21 /... Representatives passing the landmark Affordable H...nate moving key health reform legislation forward,...on,s broken health care system. Today, AARP hoste...
(Date:11/21/2009)... HAPPYneuron,s most popula... on the iPhone and iPod Touch. , ...9 -- HAPPYneuron,s most popular and addictive game...Pod Touch. Split Words is designed to help banish ...e SplitWords iPhone brain game challenges the br...
(Date:11/20/2009)..., , Pioneering Neurologist Closer to Underst... Nov. 20 Dr. Jeremy Sch... School and neurologist at the Massachusetts Gener...resented his laboratory,s research on the new fiel...the MINDlink Foundation. ,, Dr. Schmahmann is a...
(Date:11/20/2009)..., , QUINCY, Mass., Nov. 20 F...Supermarket Company removed from sale Shedd,s Coun...li Rice and Shedd,s Country Crock ® Side Dish...ulfite allergen. ,, The following code dates a... ® Side Dishes DELUXE Cheddar Broccoli Rice 2...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2
...t almost 60 percent of pacemaker patients had undi...ributed to their heart disease//. This study is re...rt Association. Moreover, more than 21 perce...., Ph.D., senior author of the study and a profess...
...die of heart disease than of any other cause, led ...ether kill// roughly 900,000 people a year. An..., says Benjamin D. Horne, director of cardiovascul...oned-in questions about genetics and heart disease...
...all breast tumors don’t need chemotherapy to reduc...To try to determine who does, a test that measures... tested nationally in more than 10,000 of these wo...r. Thomas A. Samuel, Medical College of Georgia he...
...ss whether meat and dairy products from cloned ani...Safety Authority (EFSA) was asked by the European ...stock cloning. At present, there is no spe...d that products from cloned animals were safe. ...
...scheme has given a new meaning to life for thousan...unity// and HIV positive people in Tamil Nadu. ...(TAI) and the Voluntary Health Service (VHS) aims ...them to TAI centres and later open bank accounts. ...
...wing body of research and leading experts show tha...likely// to agree to hospice and palliative care, ...hy, is the difficult part. Some believe that it ma... Yet others believe that "people with higher incom...
Other Medicine News:Health News:Pacemaker Patients Should Be Screened for Sleep Apnea 2Health News:Genetics may Play Role in Heart Health 2Health News:Study Aims to Find Which Breast Cancer Patients Need Chemotherapy 2Health News:Study Aims to Find Which Breast Cancer Patients Need Chemotherapy 3Health News:EU to Look at Cloned Meat Safety 2Health News:Unique Savings Scheme Aids Sex Workers 2Health News:Unique Savings Scheme Aids Sex Workers 3Health News:Minorities Likely to Keep Fighting Death to the End 2
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: